Skretting and eniferBio have signed a Memorandum of Understanding (MoU) on continued cooperation. In this way, they have strengthened their partnership which will define the future steps for testing PEKILO® protein in Atlantic salmon and rainbow trout.
In 2021, tests on PEKILO® with Atlantic salmon were first done. After the agreement, the Finnish biotech start-up has now provided a new batch of PEKILO® protein for the next phases of testing. This will consist of its performance as an aqua feed with Atlantic salmon. Moreover, the first performance testing rounds with rainbow trout.
eniferBio was the winner of the 2020 Nutreco Feed & Food Tech Challenge. The first prize included a scientific validation trial. Besides, it rewards the best breakthrough innovations within livestock farming, aquaculture, and alternative food proteins.
To sum up, Mette Lütcherath, Category Manager of Novel Ingredients at Nutreco explained how MoU will set the standards for PEKILO® protein commercialization. Also, “the implementation into Skretting feeds, in line with our sustainability ambitions of including 5-10% of novel ingredients into our formulations by 2025. There is a strong intention from both parties to reach large commercial volumes of this low carbon, high-protein novel raw material; first in Europe and subsequently in other geographies.”
Furthermore, Joosu Kuivanen, COO and co-founder of eniferBio, added: “Skretting is a leading manufacturer and supplier of aquaculture feeds, so it is significant to get help from a major company like them in getting our innovation out there. We are thrilled that the first round of performance tests was a success, and we can continue the partnership.”